TI
HARP

Telemetry Investments’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Telemetry Investments’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$67K Buy
+9,300
New +$78.3K 0.11% 96

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Telemetry Investments's HARP Position: Q4 2022 in Review

Telemetry Investments opened a new position in Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2022: 9,300 shares worth $67K. The stake represents 0.11% of the portfolio and ranks #96 among its holdings.

49 funds tracked by Wall St. Rank hold HARP as of Q4 2022.

  • Telemetry Investments held 9,300 shares of Harpoon Therapeutics, Inc. Common Stock worth $67K as of Q4 2022.
  • Harpoon Therapeutics, Inc. Common Stock was a new Telemetry Investments position in Q4 2022.
  • Harpoon Therapeutics, Inc. Common Stock made up 0.11% of Telemetry Investments's portfolio in Q4 2022, its #96 holding.
  • 49 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.